Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine

Irritable Bowel Syndrome (IBS) and Chronic Constipation

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

Gastroenterology.

Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, Surawicz CM, Chey WD

doi: 10.1053/j.gastro.2019.06.014.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation

Am J Gastroenterol.

Shah ED, Suresh S, Jou J, Chey WD, Stidham RW

doi: 10.14309/ajg.0000000000000530.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea

Qual Life Res.

Abel JL, Carson RT, Andrae DA

doi: 10.1007/s11136-018-2008-z.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

Am J Gastroenterol.

Rezaie A, Heimanson Z, McCallum R, Pimentel M

doi: 10.14309/ajg.0000000000000444.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea

Adv Ther.

Brenner DM, Sayuk GS

doi: 10.1007/s12325-019-01116-z.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome

doi: 10.1016/j.amjmed.

RECOMMENDED

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Predicting response to rifaximin in irritable bowel syndrome with diarrhea: Is the answer blowing in the wind?

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Gastroenterology.

Black CJ, Ford AC

doi: 10.1053/j.gastro.2020.02.018.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Am J Gastroenterol.

Brenner DM, Sayuk GS, Gutman CR, Jo E, Elmes SJR, Liu LWC, Cash BD

doi: 10.14309/ajg.0000000000000327.

Related content

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation

The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea

Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome

Predicting response to rifaximin in irritable bowel syndrome with diarrhea: Is the answer blowing in the wind?

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study